Data de publicació electrònica: 04/03/2021Introduction: The association between cerebral amyloid-β accumulation and downstream CSF biomarkers is not fully understood, particularly in asymptomatic stages. Methods: In 318 cognitively unimpaired participants, we assessed the association between amyloid-β PET (Centiloid), and cerebrospinal fluid (CSF) biomarkers of several pathophysiological pathways. Interactions by Alzheimer's disease risk factors (age, sex and APOE-ε4), and the mediation effect of tau and neurodegeneration were also investigated. Results: Centiloids were positively associated with CSF biomarkers of tau pathology (p-tau), neurodegeneration (t-tau, NfL), synaptic dysfunction (neurogranin) and neuroinflammation (YKL-40, GFAP, s...
It is currently unclear how amyloid-β and tau deposition are linked to changes in synaptic function ...
Astrocytes can adopt multiple molecular phenotypes in the brain of Alzheimer's disease (AD) patients...
Background: The search for a biomarker of Alzheimer's disease (AD) pathology (amyloid-β (Aβ) and tau...
Introduction: Several neurodegenerative brain proteinopathies, including Alzheimer's disease (AD), a...
Introduction We investigated relations between amyloid-β (Aβ) status, apolipoprotein E (APOE) ε4, an...
INTRODUCTION:Amyloid-β (Aβ) and tau accumulations may occur independently and concurrently as exempl...
The relationships between β-amyloid (Aβ), tau and neurodegeneration within Alzheimer's Disease patho...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
The links between β-amyloid (Aβ) and tau in Alzheimer's disease are unclear. Cognitively unimpaired ...
AIMS: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especia...
The links between β-amyloid (Aβ) and tau in Alzheimer's disease are unclear. Cognitively unimpaired ...
International audienceOBJECTIVE: To investigate the relationship between cerebrospinal fluid (CSF) β...
OBJECTIVE: To investigate the association between discordant β-amyloid (Aβ) PET and CSF biomarkers a...
Objective: To investigate the association between discordant amyloid-β PET and CSF biomarkers at bas...
See Vandenberghe and Schaeverbeke (doi:10.1093/awx065) for a scientific commentary on this article. ...
It is currently unclear how amyloid-β and tau deposition are linked to changes in synaptic function ...
Astrocytes can adopt multiple molecular phenotypes in the brain of Alzheimer's disease (AD) patients...
Background: The search for a biomarker of Alzheimer's disease (AD) pathology (amyloid-β (Aβ) and tau...
Introduction: Several neurodegenerative brain proteinopathies, including Alzheimer's disease (AD), a...
Introduction We investigated relations between amyloid-β (Aβ) status, apolipoprotein E (APOE) ε4, an...
INTRODUCTION:Amyloid-β (Aβ) and tau accumulations may occur independently and concurrently as exempl...
The relationships between β-amyloid (Aβ), tau and neurodegeneration within Alzheimer's Disease patho...
Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD)...
The links between β-amyloid (Aβ) and tau in Alzheimer's disease are unclear. Cognitively unimpaired ...
AIMS: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especia...
The links between β-amyloid (Aβ) and tau in Alzheimer's disease are unclear. Cognitively unimpaired ...
International audienceOBJECTIVE: To investigate the relationship between cerebrospinal fluid (CSF) β...
OBJECTIVE: To investigate the association between discordant β-amyloid (Aβ) PET and CSF biomarkers a...
Objective: To investigate the association between discordant amyloid-β PET and CSF biomarkers at bas...
See Vandenberghe and Schaeverbeke (doi:10.1093/awx065) for a scientific commentary on this article. ...
It is currently unclear how amyloid-β and tau deposition are linked to changes in synaptic function ...
Astrocytes can adopt multiple molecular phenotypes in the brain of Alzheimer's disease (AD) patients...
Background: The search for a biomarker of Alzheimer's disease (AD) pathology (amyloid-β (Aβ) and tau...